Lipocalin 13 Protein Protects against Hepatic Steatosis by Both Inhibiting Lipogenesis and Stimulating Fatty Acid β-Oxidation

Obesity is associated with hepatic steatosis, partially due to increased lipogenesis and decreased fatty acid β-oxidation in the liver; however, the underlying mechanism of abnormal lipid metabolism is not fully understood. We reported previously that obesity is associated with LCN13 (lipocalin 13)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sheng, Liang, Cho, Kae Won, Zhou, Yingjiang, Shen, Hong, Rui, Liangyou
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Biochemistry and Molecular Biology 2011
Gaiak:
Metabolism
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3207413/
https://ncbi.nlm.nih.gov/pubmed/21908604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M111.256677
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak